Chemical Peel in Paris France
Chemical Peel
It's a procedure in which a controlled chemical burn is applied to the skin using chemical solution in order to remove outer layers of the skin. It can remove delicate wrinkles, pigmentation marks and other skin defects. Peeling also has some medical advantages like removal of pre cancerous conditions and acne scars.
The solutions being used are phenol, trichloroacetic acid (TCA) and alphahydroxil acids (AHA).
AHA is used for delicate peeling, it gives you smooth and shine skin, and it also treats delicate wrinkles, acne scars and pigmentation. Several treatments usually required on weekly bases. The solution can also be incorporated into cr?mes or facial wash and can be used on daily bases.
TCA is used for intermediate peeling. It removes wrinkles and superficial skin defects and pigmentation. Usually more then one treatment required and it has longer healing times then AHA. It can be used in whole body parts.
Phenol is the most powerful solution, which is used for deep peeling. It removes deep wrinkles, pre malignant conditions and skin defects due to sun exposure; it also causes brighter skin color. It can be used only in the face area.
It is recommended to use several creams before the peeling to get better results. Retin-A thinners the upper layers of the skin and hydroquinone which bleaches the skin.
The peeling is done by the following techniques: AHA - after the cleaning of the skin the doctor spreads the solution on the skin. It takes 10 minutes, afterwards the doctor gives you instructions how to use this cream for several weeks at home.. During those weeks you'll be invited for check up to follow the progress of peeling.
TCA - usually takes 45 minutes. You may feel a burning sensation which disappears after a few minutes. Second treatments usually done with an interval of a couple of month.
Peeling with phenol lasts 1-2 hours. One treatment usually sufficient. You'll need to cover the face with a bandage or Vaseline cream.
After the treatment with AHA you can immediately return to daily activities, but you must wear sunscreen. TCA causes redness and swelling which disappears during the week, you can return to work after 7-10 days. After the use of phenol skin regeneration usually takes 7-10 days. At first you'll have a very reddish skin that will gradually change to pink color. It is very important to avoid direct sun exposure and use sunscreen to avoid burns and pigmentation.
More Paris info...
Paris Boat
There is an excellent boat service which makes use of the Seine. As well as providing easy, cheap transport to much of central Paris, excellent photo opportunities abound. You can buy a day or 3 day ticket and hop on and off the boat as needed. The boat takes a circular route from the Eiffel Tower, down past the Louvre, Notre Dame, botanical gardens then back up the other bank past Musee D'orsay.
-
Paris History
Paris started life as the Celto-Roman settlement of Lutetia on the ?le de la Cit?. It takes its present name from the name of the dominant Gallo-Celtic tribe in the region, the Parisii. At least that's what the Romans called them, when they showed up in 52 BCE and established their city Lutetia on the left bank of the Seine, in what is now called the "Latin Quarter" in the 5th arrondissement.
-
Plastic Surgery News...
- A Clinical Picture described in the February 16, 2008 issue of TheLancet underlines the perils of using skin lightening creams sold onthe black market. Dr. Tricia Tan and Dr. Tony Goldstone of theEndrocrine Unit in the Department of Investigative Medicine, ImperialCollege Healthcare NHSTrust, Hammersmith Hospital, London, UK, were involved in the team that treated thepatients and co-authored this piece. The woman, at 28 years old, had gained 12.7 kg (28.
- The MHRA has notified companies that hold authorisations for antidepressant products that they will shortly be receiving letters requesting Type II variations to update the warnings on suicidal thoughts and behaviour in line with European agreements. The Pharmacovigilance Working Party (PhVWP) had considered the results of a meta-analysis of adult clinical trial data for SSRIs and other antidepressants recently completed by the FDA. It agreed that the ‘EU core SPC for SSRIs and related substances’ of October 2005 should be modified with regard to suicidality and should now be extended to cover all antidepressants. In particular, the wording should be updated with respect to the increased risk to young adults and the need for close monitoring of patients, and it will be applicable to all antidepressants, not only SSRIs. The timetable for implementation has also been agreed at European level to ensure that healthcare professionals, patients and their carers receive this important safety information as soon as possible.